BC Platforms Acquires Medexprim, Paving the Way for Global Leadership in Real-World Data and Real-World Evidence Analytics

BC Platforms, a global leader in healthcare data management and analytics, today announced it has acquired Medexprim, a leading European Real-World Data company. The acquisition significantly expands BC Platforms’ ability to provide global biopharma partners with secure access to Real-World clinical and imaging Data assets across Europe. Medexprim bridges leading hospitals and pharmaceutical companies, with a [...]

Advion Interchim Scientific Announces Appointment of Jamey Jones, to Chief Executive Officer

ITHACA, N.Y., USA, / MONTLUÇON, FRANCE — Advion Interchim Scientific, renowned for its expertise in mass spectrometry and chromatography instruments and consumables, announced today that Jamey Jones will immediately become Chief Executive Officer of the Advion Interchim Scientific group. The appointment encompasses the chief leadership role at both Advion Inc. and Adchim (Interchim group), two companies [...]

Stefan Müller to become new Chief Financial Officer of Carl Zeiss AG

Stefan Müller, currently Chief Financial Officer of Paul Hartmann AG and previously member of the Management Board of the ZEISS Industrial Quality & Research segment, will take on the position of Chief Financial Officer of Carl Zeiss AG starting 1 January 2024. OBERKOCHEN, Germany -- The Supervisory Board of Carl Zeiss AG has appointed Stefan [...]

Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution

Biotage® PeptiPEC high-throughput kits facilitate fast and low solvent consumption solution for plate-based peptide purification Partnership complements Gyros’ PurePep® EasyClean technology offering with an automated solution for advanced discovery process Uppsala, Sweden: Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, and Biotage, a global life sciences company, providing [...]

10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain

PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a collaboration with the NIH Intramural Center for Alzheimer's and Related Dementias (NIH CARD) to build a more comprehensive single cell atlas of the human brain to further neuroscience research. Known for complementing a broad range of NIH-funded research that requires harnessing [...]

IonOpticks and Newomics broaden chromatography accessibility for Agilent mass specs, with Shimadzu pending

MELBOURNE, Australia -- IonOpticks, the world leader in high performance liquid chromatography for mass spectrometry, is proud to announce an exciting collaboration with Newomics Inc. that has produced an interface solution for their flagship Aurora Series columns and Agilent mass spectrometers. IonOpticks is renowned for its class-leading chromatography solutions, particularly the Aurora Series, which are [...]

Four’Es Scientific Partners with Bioz to Empower Researchers with the Integration of Bioz Badges

PALO ALTO, Calif.  - Bioz, Inc., a leading AI software company based in Silicon Valley, is thrilled to announce its partnership with Four E's Scientific, a US-based leading provider of cutting-edge scientific equipment and solutions. With an impressive range of laboratory products, Four E's Scientific has been providing laboratories around the world with quality instruments since [...]

Merck KGaA, Darmstadt, Germany, Collaborates with Acceleration Consortium on Open-Sourcing AI-Driven Experimentation Planner

AI-driven experimentation planner BayBE (Bayesian Back End) by us and Acceleration Consortium is available open-source on GitHub Bayesian optimization engine that already powers dozens of use cases at Merck KGaA, Darmstadt, Germany, now open sourced to foster adoption Close partnership to enable the self-driving labs of tomorrow Merck KGaA, Darmstadt, Germany, a leading science and [...]

Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board

Supports ambitious commercialisation strategy for DNA synthesis platform, gSynth Follows $10m Series A financing to scale operations   Cambridge, UK: Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has appointed Dr Nicola Thompson as Chair of its Board of Directors. Following its $10 million Series A financing earlier in [...]

Evonetix Announces Agreement for Revolutionary Gene Synthesis Platform with Analog Devices

The companies are working together on next-generation technology in the fast-growing field of synthetic biology. This new technology will improve the quality, speed, and cost of developing synthetic biological solutions such as life-saving vaccines, medicines, treatments, and therapies. Cambridge, UK  – EVONETIX LTD (‘Evonetix’), the company developing semiconductor scale technology to improve access to gene synthesis, today [...]

Access IBO on Knowledge Center